Nasdaq notifies Predictive Oncology of bid price deficiency; 180-day cure period to Jan 5, 2026

Axe Compute Inc.

Received Nasdaq letter on July 8, 2025 for failure to maintain minimum $1.00 bid price over 30 consecutive days.
Company has until January 5, 2026 to regain compliance by closing at or above $1.00 for 10 consecutive days.
If not cured by Jan 5, may be eligible for a second 180-day period if other listing standards are met.
Company intends to monitor bid price and consider options including a potential reverse stock split.
Failure to cure could result in delisting from Nasdaq Capital Market, subject to appeal rights.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.